Medical Technology Company Achieves Breakthough In Organ Preservation and Transportation

The days when human organs used for transplants are stored in plastic bags and placed in Styrofoam containers are numbered. Organ Transport Systems, Inc (OTS) developed a human organ preservation technology that will dramatically improve the quality and increase the availability of vital organs.

Called Life Cradle™, it will drastically elevate a US$ 9 Billion dollar industry by improving the preservation and transportation of human organs by 80% of current US statistics. More so, the cost of Life Cradle ™ is just around 25% of current competing technologies.

As of the present, organs can only be stored up to 4 hours before transplant of which only 35% of organs procured are actually used. OTS Chairman and CEO, Michael B. Holder, stated that post-procurement life of organs like heart can be extended up to 4 times longerwith Life Cradle™. Prolonging the storage of organs will dramatically increase the number of lives that can be saved.

The Oxford Group of Unilion Development Group (UDG), a private equity firm, led by Jerome Gentolia, is in talks with OTS to finance the project. Mr. Gentolia, whose wife is a heart transplant coordinator at Montefiore Medical Center, got interested in the project because of his familiarity with the industry and the personalities behind OTS.

According to Gentolia, “Life Cradle™ is a perfect example of what UDG looks for in a project; a focused company, innovative technology and a direct benefit to people around the world…”

The OTS roster boasts of the top men in their respective field. Michael B. Holder, prior to his role in OTS, ran the Technology Solutions business for Premier, Inc, an $18 Billion healthcare company.

The OTS Board of Directors consists of:

·         Tommy G. Thompson, former Secretary of Health and Human Services;

·         Gene A. Pierce, founder of United Network for Organ Sharing (UNOS) and the South East Organ Procurement Foundation;

·         Marvin J. Slepian MD,  Director of Interventional Cardiology and the Director of the Tissue Engineering Laboratory at the University of Arizona Sarver Heart Center

OTS is founded by Hyman P. White, whose international experience includes the complete development of master health care plans for both Malaysia and Indonesia. He currently serves as Executive Vice President of OTS.

Jerome Gentolia is the Chief Operating Officer of Unilion Oxford Group and also the Senior Vice President of Unilion Development Group, a private equity firm. He can be reached at jgentolia@uhl-unilion.com

Green Fuels LLC signs US $220 Million Deal to Fund Bio-Diesel

NEW YORK – Jerome Gentolia has secured a $220 million deal for Indianapolis, Indiana based Green Fuels LLC. This is the fourth bio-fuel project that members of Green Fuels LLC’s management team have been an integral part of, with three key executives having previously served as plant managers for other ethanol and bio-diesel plants.

The deal by Gentolia is in conjunction with a Wall Street based structured project finance company that will serve as investing Collateral Guarantor for Green Fuels and provide a direct contribution of cash-backed banknote instruments as full collateral backing for the complete financing package.

“The Green Fuels management team is sophisticated, experienced, and very successful at choosing, acquiring, permitting, and operating efficient bio-fuel plants. Beyond that, an important factor for us is that their primary feedstock is not used as food for humans or animals, thus not having an adverse impact on growing global food shortage issues, which is a growing concern with some methods of alternative energy production,” said Gentolia.

“It is a business that we choose to be in and are proud to be a part of.  America needs more cost-effective energy, reduced air pollutant emissions, and a reduction in the reliance on imported oil,” said a Green Fuels LLC representative of their current plans to build 4 bio-diesel plants in Indiana and 1 in Illinois over the next few years, adding that “as technology changes – which is now rapidly occurring in this industry – new opportunities and methodologies to produce bio-fuels likely will emerge and we are open to pursuing those future possibilities, as well.”

JMK Hospitality, Inc Signs $381 Million Deal for Several Luxury Hotel Projects in U.S. Mid-Atlantic

NEW YORK – Jerome Gentolia has secured a $381 million deal for North Carolina based JMK Hospitality, Inc., which was formed to invest in and manage existing hotel properties, as well as to develop upscale properties, in the Mid-Atlantic region (NC, SC, GA, VA, WV) of the United States.

The deal by Gentolia, in conjunction with a Wall Street based structured project finance company which will serve as investing Collateral Guarantor for JMK and provide a direct contribution of cash-backed banknote instruments as full collateral backing for the complete financing package, will be utilized for acquisition and development of numerous luxury properties, capitalizing on the Mid-Atlantic Region’s tremendous recent growth, marked by the increasing strength of it’s tourism industry.

This burgeoning region, stretching from Virginia and West Virginia in the North to Georgia in the South, boasts 3 of the Top 10 Most Visited US States, according to the Travel Industry Association website. (http://www.tia.org/pressmedia/fast_fact_states.html)

“The management team behind JMK breeds a great deal of confidence,” remarked Gentolia. “Co-Founders James Bazluki, Matthew D. Adams and Kimberly Scott each bring a wealth of general business, legal and hospitality-industry experience, and we have every reason to believe that they will achieve their business objectives. We want to be a part of what they’re doing.” 

Jerome Gentolia can be reached at: jgentolia@internationalprojectfinance.net